Breast Cancer Index and Recommendations for Extended Endocrine Therapy

Tara B. Sanft, Natalia Siuliukina, Brandon O’Neal, Niloufar Khojandi, Rachel C. Jankowitz, Mark D. Pegram, Sami Diab, Yi Zhang, Amanda K.L. Anderson, Kai Treuner, Joyce A. O’Shaughnessy · 2026

Read Breast Cancer Index and Recommendations for Extended Endocrine Therapy by Tara B. Sanft, Natalia Siuliukina, Brandon O’Neal, Niloufar Khojandi, Rachel C. Jankowitz, Mark D. Pegram, Sami Diab, Yi Zhang, Amanda K.L. Anderson, Kai Treuner, Joyce A. O’Shaughnessy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13613174.txt.

Description

Tara Sanft and co-authors reported in 2026 how a gene test changed advice on extended hormone therapy for early breast cancer. The test estimates late return risk and who gains from more years of hormone pills. In an earlier registry report, doctors changed advice for over forty percent of patients after testing. This report covers the full United States registry cohort enrolled from 2021 to 2024.

The final group held 2,900 women with both doctor and patient surveys. After testing, about forty-two percent of doctors changed their advice, and half the patients changed their own preference. Among women the test flagged as likely to gain, advice for extended therapy jumped sharply. The authors say the test shapes real decisions, not just risk talk.

Catalog record

CREATORTara B. Sanft, Natalia Siuliukina, Brandon O’Neal, Niloufar Khojandi, Rachel C. Jankowitz, Mark D. Pegram, Sami Diab, Yi Zhang, Amanda K.L. Anderson, Kai Treuner, Joyce A. O’Shaughnessy
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13613174

Browse the full library · About the Tower of Babel